Medicare Part D Changes Not Overwhelming, Experts Say
THURSDAY, Nov. 11 (HealthDay News) -- Seniors enrolled in
Medicare Part D prescription drug plans will come across some
changes as they choose a new plan or reassess an old one during the
upcoming open enrollment period, but experts say those differences
won't be monstrous.
Are You at Risk of Developing Diabetes?
THURSDAY, Nov. 11 (HealthDay News) -- Diabetes is a leading
cause of death in the United States, and Americans need to know the
risk factors and what they can do to prevent and treat the disease,
says the American College of Physicians.
Urine Markers May Reveal Kidney Damage Earlier
THURSDAY, Nov. 11 (HealthDay News) -- Researchers have
pinpointed certain markers in urine that may indicate acute kidney
injury (AKI), a finding they believe could lead to a simple urine
test to diagnose AKI early and prevent kidney failure.
Many Kids Skipping Meals, Snacking Instead
THURSDAY, Nov. 11 (HealthDay News) -- Many U.S. children are
eating more snacks and skipping breakfast and dinner, meals that
provide nutrients critical to youngsters' development, behavior and
overall health, a new survey has found.
High Cholesterol in Middle Age May Not Raise Dementia Risk for Women
THURSDAY, Nov. 11 (HealthDay News) -- For years, doctors have
been saying that keeping your cholesterol levels in check as you
age is good for your brain as well as your heart, but a new study
suggests the connection between cholesterol and dementia later in
life isn't quite so clear-cut.
Egrifta Approved for HIV-Related Fat Deposits
THURSDAY, Nov. 11 (HealthDay News) -- Egrifta (tesamorelin) has
been approved by the U.S. Food and Drug Administration to treat fat
deposits caused by HIV-related lipodystrophy. The condition may
cause fat deposits around the liver, stomach, and other abdominal
Severe Acne May Up Suicide Risk: Study
THURSDAY, Nov. 11 (HealthDay News) -- Severe acne may
significantly increase suicide risk, and patients taking
isotretinoin (Accutane) for the skin condition should be monitored
for at least a year after treatment ends, Swedish researchers